Supernus Pharmaceuticals, Inc. 0LB2.L
0LB2.L
Supernus Pharmaceuticals, Inc. 0EE0.L
uniQure N.V. 0HF9.L
Amicus Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0Y5E.L
Perrigo Company plc 0IDA.L
Dynavax Technologies Corporation 0VQA.L
Viking Therapeutics, Inc. 0KCS.L
OPKO Health, Inc.
Supernus Pharmaceuticals, Inc. 0EE0.L
uniQure N.V. 0HF9.L
Amicus Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0Y5E.L
Perrigo Company plc 0IDA.L
Dynavax Technologies Corporation 0VQA.L
Viking Therapeutics, Inc. 0KCS.L
OPKO Health, Inc.
Performance
| Periode | 0LB2.L | 0EE0.L | 0HF9.L | 0HB0.L | 0L35.L | 0JBU.L | 0Y5E.L | 0IDA.L | 0VQA.L | 0KCS.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 65.93 % | 331.02 % | 19.01 % | 43.94 % | -62.07 % | 213.60 % | -13.81 % | -3.81 % | 39.12 % | 6.30 % |
| YTD | 46.28 % | 237.84 % | -7.43 % | 27.64 % | -81.62 % | 111.49 % | -17.69 % | -20.95 % | -15.71 % | 1.31 % |
| 1Y | 54.36 % | 796.64 % | -24.84 % | -7.65 % | -82.22 % | 56.51 % | -15.50 % | -8.11 % | -54.16 % | 1.99 % |
| 3Y | 53.16 % | 225.15 % | -19.79 % | 46.91 % | -79.78 % | -51.98 % | -35.15 % | -11.51 % | 707.40 % | -20.55 % |
| 5Y | 142.82 % | 41.62 % | -8.69 % | 25.06 % | -70.08 % | -73.40 % | -35.15 % | -10.11 % | 455.17 % | -50.35 % |
| 10Y | 28.18 % | 216.76 % | -8.69 % | -47.08 % | -70.08 % | -73.40 % | -35.15 % | -10.11 % | 136.59 % | -50.35 % |
| Depuis le début | 28.18 % | 216.76 % | -8.69 % | -47.08 % | -70.08 % | -73.40 % | -35.15 % | -10.11 % | 136.59 % | -50.35 % |